The c-Myb transcription factor regulates the differentiation of immature erythroid, lymphoid, and myeloid cells, although only the latter cells become transformed by the v-myb oncogene. These are also the only cells that express the Myb-regulated gene mira-l, suggesting that Myb requires tissue-specific, cooperating factors to activate such genes. Here, we investigated the tissue-specific regulation of the mdm-1 promoter and found that it not only contains binding sites for Myb but also for NF-M, a myeloid-specific transcription factor that probably corresponds to mammalian C/EBPI~. Both types of binding sites were found to be required for full activity of the promoter. Remarkably, ectopic coexpression of Myb and NF-M proteins in erythroid cells or fibroblasts was sufficient to induce endogenous markers of myeloid differentiation, like the mira-1 and lysozyme genes. Our results indicate that c-Myb and NF-M proteins act as a bipartite, combinatorial signal that regulates the expression of myeloid-specific genes, even in heterologous cell types.
c-myb gene is high in immature myeloid, crythroid, and lymphoid cells and decreases as these cells differentiate (Gonda et al. 1982; Duprey and Boettiger 1985; Kastan et al. 19891 . Third, ectopic expression of c-myb in immature erythroid cells has been shown to block their differentiation (Clarke et al. 1988; Todokoro et al. 1988; McClinton et al. 1990) , and antisense oligonucleotides specific for c-myb block both the differentiation and the proliferation of hematopoietic cells in tissue culture (Gewirtz and Calabretta 1988; Gewirtz et al. 1989) . Finally, transgenic mice with both copies of their c-myb gene disrupted are deficient for definitive hematopoiesis and die in utero (Mucenski et al. 1991) .
The Myb products define a family of nuclear-localized, DNA-binding proteins, found in eukaryotic species from yeasts to mammals {Katzen et al. 1985; Paz-Ares et al. 1987; Tice-Baldwin et al. 1989 ]. They share a unique DNA-binding domain structure composed of two or three -52-amino-acid-long homeo domain-like units Saikumar et al. 1990; Frampton et al. 1991; Gabrielsen et al. 1991) . In vertebrates, all of the Myb proteins recognize a common binding site and function as transcriptional activators (Boyle et al. 1984; Klempnauer et al. 1984; Biedenkapp et al. 1988; Ness et al. 1989; Nishina et al. 1989; Weston and Bishop 1989; Ibanez and Lipsick 1990; Kalkbrenner et al. 1990; Nakagoshi et al. 1990) , suggesting that the oncogene transforms cells by altering the expression of specific target genes. The availability of a temperature-sensitive mutant of E26 virus {Beug et al. 1984 ) facilitated the identification of the first Myb-regulated gene, mira-1. The promoter of this gene contains three binding sites for Myb, and its activity depends on the presence of active Myb proteins {Ness et al. 1989) . Although the function of mim-1 remains unknown, it nevertheless provides a system in which to study how Myb proteins regulate the transcription of a bona fide target gene.
The identification of mira-1 as a Myb-regulated gene raised several questions. For example, although c-myb is expressed in different types of hematopoietic and lymphoid cells, and transfection of mature myeloid cells with c-myb induced mira-1 gene expression, mira-1 mRNA was only detectable in promyelocytes {immature neutrophil granulocytesl, a small subset of the cell types that express Myb (Queva et al. 1992) . This suggested that another, unidentified cell type-specific factor might be required together with Myb to activate m i m -I expression, and perhaps other myeloid-specific genes as well. One candidate transcription factor that could play such a role is NF-M, which was first identified because it activates the expression of the gene encoding cMGF, a chicken myelomonocytic-cell-specific cytokine (Sterneck et aI., 1992) . NF-M is a member of the CCAAT/ enhancer-binding protein (C/EBP) family and probably represents the chicken homolog of C/EBPf~ Katz et al. 1993) .
The C/EBP-like transcription factors are a family of so-called bZip proteins, characterized by a basic DNAbinding region that is linked to a leucine zipper dimerization motif. The family contains three closely related members that include C/EBP~, C/EBP~ (also called NF-IL6, LAP, IL6-DBP, AGP/EBP, and CRP2), and C/EBP8 (CRP3, CELF; Landschulz et al. 1988; Birkenmeier et al. 1989; Akira et al. 1990; Chang et al. 1990; Descombes et al. 1990; Poli et al. 1990; Kageyama et al. 1991; Williams et al. 1991) . The proteins have overlapping but distinct temporal patterns of expression during adipogenesis and myelomonocytic differentiation (Cao et al. 1991; Scott et al. 19921 , and they form homo-or heterodimeric DNAbinding complexes that recognize similar regulatory elements in a sequence-specific manner. In an analogous fashion to c-Myb, C/EBPc~ and C/EBPf3 are capable of regulating genes in different cell types, such as albumin in the liver and 422aP2 in adipocytes (Lichtensteiner et al. 1987; Cheneval et al. 1991) . This tissue specificity is thought to result from combinatorial interactions with unrelated transcription factors bound to adjacent stretches of DNA (Descombes et al. 1990; Lamb and McKnight 1991) .
Here, we describe that the induction of the mim-1 promoter not only requires the binding of Myb but also of NF-M. We also show that ectopic expression of NF-M in nonmyeloid cells allows Myb to activate both the mim-1 and lysozyme genes in inappropriate cell types. Our results demonstrate a cooperation between NF-M and Myb, implicating them as a bipartite "molecular switch" that determines the differentiation fate of myeloid cells.
to invert two nucleotides so that the TAAC core was changed to TACA. Mobility-shift assays and DNase I footprinting experiments confirmed that the altered promoters were unable to bind bacterially expressed Myb proteins (data not shown). A number of 5'-end deletion mutants were also made, resulting in test constructs containing progressively shorter and shorter upstream sequences. All promoter constructs were reintroduced into a luciferase reporter gene plasmid, and their activities were tested in transient cotransfection assays.
As shown in Figure 1 , the point mutations affecting the A box, the highest affinity Myb-binding site, blocked the ability of Myb to activate the promoter, resulting in a construct with very little residual activity. In contrast, disrupting the lower affinity B and C boxes, either individually (not shown) or in combination, had no effect on the activity of the promoter (Fig. 1) . Similarly, deletions extending up to position -175, which removed both the C and B boxes, had no detrimental effect on the promoter. This indicates that, at least in the context of these mim-1 promoter-reporter gene constructs, only the high-affinity A-box site is necessary for Myb inducibility and that multiple Myb-binding sites are not required to render the mira-1 promoter activatable by Myb. It also suggests that no sequences upstream of position -175 are required for the type of promoter activity detected in these cotransfection experiments. In contrast, deletions extending beyond position -161, in the region between the A and B boxes, eliminated mim-1 promoter activity. DNA-binding experiments indicated that the -161 deletion did not affect the ability of bacterially expressed Myb protein to bind the promoter at the A-box site (not shown), ruling out the trivial explanation that those sequences might be required for Myb binding and suggesting that another, as yet unidentified,
R e s u l t s
The mim-1 promoter binds tissue-specific factors in addition to Myb
The mim-1 gene was originally identified as a v-Mybregulated gene. In spite of this, it was only found to be expressed in a subset of v-Myb-expressing cells (Ness et al. 1989) . This suggested that tissue-specific factors cooperate with Myb to activate the gene. A mutational analysis of the mira-1 promoter was therefore performed to identify potential binding sites for myeloid-specific transcription factors. The first mutations made were in the Myb-binding sites, designated as the A, B, and C boxes, that are centered 145, 184, and 206 nucleotides upstream of the start site of mira-1 transcription, respectively. In each case, site-directed mutagenesis was used 
NF-M binds adjacent to Myb on the mim-1 promoter
The mutational analysis indicated that a tissue-specific protein binds the mim-1 promoter between positions -175 and -155 (the distal side of the A box). This was particularly interesting because the sequence contained a potential binding site for chicken NF-M {Sterneck et al. 1992 ), a transcription factor that probably represents the chicken version of C/EBP~. NF-M was first identified as a regulator of the cMGF gene, which encodes a myeloidspecific cytokine required for the growth of v-myb-transformed cells, which, in turn, is expressed in the same cells as mira-1 (Stemeck et al. 1992}. The cMGF promoter contains two NF-M-binding sites, both of which are required for myelomonocyte-specific activity (Sterneck et al. 19921 . Because other proteins in the C/EBP family are known to be involved in tissue-specific gene regulation (Poli et al. 1990; Umek et al. 19911 , NF-M seemed a good candidate for the myeloid-specific protein implicated in mim-1 activation. We therefore examined the mim-1 promoter for potential NF-M-binding sites by DNase I footprinting and mobility-shift assays.
NF-M protein was synthesized in bacteria, partially purified (Katz et al. 1993) , and used for DNase I footprinting assays, which identified two binding sites for recombinant NF-M in the rnim-I promoter (data not shown). Both footprints overlapped regions of the promoter containing the sequence TTxxCCAAC. The first footprint, at about position -60, was near the location of a CCAAT-like sequence. The second footprint, centered on position -160, was directly upstream of the A box, the high affinity Myb-binding site, in the region of the promoter found to be important for activation by the deletion analysis described above. We used a mobilityshift assay to determine whether the NF-M-binding sites (BS60 and BS160) in the mim-1 promoter could form a complex with myeloid cell-specific proteins. For this purpose, radiolabeled, double-stranded BS60 and BS160 oligonucleotides were incubated with nuclear extracts prepared from various cell types. As shown in Figure 2 , proteins from the myeloid cells (HD11 macrophages and E26-transformed myeloblasts), both of which express NF-M, bound to the oligonucleotide probes and formed specific, slower migrating complexes. No such complexes were formed by extracts derived from cells that do not express NF-M, such as the lymphoid cell lines RPL-12 and MSB-1, or the myeloid/erythroid progenitor cell line HD57 (Figure 2 ; Katz et al. 1993) , suggesting that NF-M was the tissue-specific protein that bound to those sites.
These results were confirmed using mobility-shift assays with nuclear extracts of COS cells expressing recombinant NF-M and with nuclear extracts from HD11 macrophages. As shown in Figure 3A , the control COS cell extracts {vector only) contained proteins that bound the mira-l-promoter probes, but the NF-M-expressing cells produced additional proteins that bound to both probes. These slower migrating complexes could be competed away with an excess of the same, unlabeled oligonucleotide but not with unrelated oligonucleotides, such as one derived from the Myb-binding A box. Finally, the addition of rabbit antiserum specific for chicken NF-M resulted in an even larger DNA/NF-M-antibody complex (a "supershift"}, whereas the preimmune serum had no effect, proving that the slower migrating complexes contained the NF-M protein. Mobility-shift assays were also used to prove that the complexes formed by myeloid cell extracts contained NF-M. As shown in Figure 3B , very similar DNA-protein complexes formed when nuclear extracts from H D l l macrophages were incubated with radioactively labeled BS60 and BS 160 oligonucleotides or with an oligonucleotide containing a previously characterized binding site for C/EBP~. The addition of excess, unlabeled A-box oligonucleotide did not interfere with formation of the complexes, although they were completely abolished by the addition of excess oligonucleotide containing the C/EBP-binding site. All the complexes reacted with anti-NF-M antiserum, but not with preimmune serum, indicating that they contained native NF-M proteins. The fact that the NF-M antiserum was able to react with all of the complexes suggests either that NF-M is the only myeloid protein that is able to bind these C/EBP-Iike binding sites or that all such sites are bound by protein complexes that contain NF-M. We conclude that the myeloid cell-specific protein NF-M binds to the mim-1 promoter at two sites, one of which, centered on position -160, is directly adjacent to the high-affinity-binding site for Myb.
NF-M cooperates with Myb to activate the

mim-1 promoter
The DNA-binding assays described above suggested a role for NF-M in the myeloid-specific activity of the mim-1 promoter. We therefore used site-directed mutagenesis to disrupt the NF-M-binding sites in the m i m -I promoter-reporter constructs and tested the effects of the mutations in cotransfection assays using HD 11 macrophages. As shown in Figure 4A , mutation of either the -160 or the -60 NF-M-binding site greatly reduced promoter activation by Myb, suggesting that both NF-Mbinding sites are required for full promoter activity. Figure 4B shows that the mim-1 promoter is activated by Myb in HD11 cells, which already express NF-M but that expression is highest when both Myb-and NF-Mexpressing plasmids are introduced into the cells. This is presumably because the additional NF-M is able to overcome some negative regulatory mechanisms that are active in these cells (Katz et al. 1993 ).
We then analyzed how a dominant-negative mutant of NF-M, 5D229, would affect the activity of the mira-1 promoter in cells expressing NF-M. 5D229 has an aminoterminal deletion that removes the trans-activation domain, leaving the DNA-binding and dimerization motifs intact. Its dominant-negative behavior is attributed to its ability to form stable, DNA-binding dimers that are unable to activate transcription (Katz et al. 1993} . As shown in Figure 4B , when 5D229 was transfected into HD11 cells, it not only failed to cooperate with Myb to activate transcription but actually inhibited the ability of Myb to activate the m i m -I promoter. Figure 4C shows that neither the truncated nor the full-length form of NF-M had any effect on the ability of Myb to activate a heterologous herpes simplex virus-thymidine kinase {HSV-TKI promoter linked to three synthetic A-box-like Myb-binding sites. This rules out the possibility that the dominant-negative 5D229 form of NF-M works by inhibiting the ability of Myb to bind to DNA or that it in some way inhibits the expression of Myb protein from the vector used in the cotransfection assays. Instead, our data suggest that 5D229 blocks the expression of m i m -I by interfering with the ability of NF-M to activate transcription, either by competing for binding sites on the mim-1 promoter or perhaps by forming inactive heterodimers with the full-length protein. We conclude that the bind-moter-reporter constructs. However, the induction of such constructs does not always parallel the activity of the endogenous mim-1 gene (Ness et al. 1989; Introna et al. 1990 ). So, the more significant question was whether either of the two transcription factors or their combination could induce the expression of the resident gene and whether this was also possible in nonmyeloid cells. We showed previously that the endogenous mim-1 gene could be activated in HD11 macrophages transfected with v-myb-or c-myb-expressing plasmids (Ness et al. 1989; Queva et al. 1992) . The Northern blots shown in Figure 5A confirm this and demonstrate that mim-1 activation is specific for Myb, as transfection with NF-M or AP-1 {los plus jun) expression vectors does not induce the gene. Coexpression of Myb and 5D229 (lanes 6), the dominant-negative m u t a n t of NF-M, partially suppresses the activation of mira-l, presumably by interfering with the endogenously expressed NF-M in those cells.
A similar experiment was performed to see whether ing of both Myb and NF-M is required for efficient expression of the mira-1 promoter in myeloid cells.
NF-M plus Myb activates the endogenous mim-1 gene m nonmyeloid cells
The cotransfection assays demonstrated that the combination of Myb plus NF-M could induce the mira-1 pro- the mim-1 gene could be induced in nonmyeloid cells. We started with the immature erythroid cell line HD3, which expresses high endogenous levels of c-myb mRNA and protein but does not express NF-M or the mim-1 gene (Ness et al. 1989 and unpubl.) . As shown in Figure 5B , transfection of HD3 cells with the NF-M expression vector alone (lanes 7) led to activation of the endogenous mira-1 gene, although the introduction of control DNAs or plasmids expressing AP-1 had no effect (lanes 10-111. This suggests that the ectopically expressed NF-M cooperated with c-myb protein to activate the gene. Interestingly, when plasmids expressing v-myb and NF-M were introduced simultaneously (lanes 9), the mim-1 gene was turned on to approximately threefold higher levels than with NF-M alone, suggesting that the endogenous levels of c-Myb protein in HD3 cells are limiting or that a functional difference between v-Myb and c-Myb makes the former protein more active in this assay. A Northern blot assay was also used to test whether the combination of Myb plus NF-M could activate the mim-1 gene in nonhematopoietic cells. The Myb and NF-M expression plasmids were transfected into primary chick embryo fibroblasts (CEFs) or the transformed quail fibroblast cell line QT6 {Moscovici et al. 1977), both of which are negative for c-Myb and NF-M expression. As shown in Figure SB , neither cell type expressed mira-1 before transfection or when the NF-M or Myb expression plasmids were introduced individually {lanes 7, 8). As before, transfection of control DNAs or an AP-1-expressing plasmid had no effect on mira-1 expression Ilanes 10, 11). However, each time that Myb and NF-M expression vectors were introduced simultaneously, the endogenous mira-1 gene was induced to high levels (lane 9). Thus, the combinatorial action of Myb plus NF-M was sufficient to induce the expression of the endogenous mirn-1 gene in every cell type tested, including cells as diverse as erythroid cells and fibroblasts.
Other C/EBP-Iike proteins can also cooperate with Myb
The previous analyses suggested that Myb and NF-M might constitute a bipartite signal for myeloid gene activation. The generality of this signal was examined by testing whether other types of C/EBP and/or Myb proteins could cooperate to activate the mira-1 gene and whether the lysozyme gene, which is known to be expressed in myeloid cells {Introna et al. 1990; Burk and Klempnauer 1991] , might also be induced by the same combination of Myb plus NF-M. Primary cultures of CEFs were transfected with various combinations of plasmids encoding E26 virus v-myb {Gag-Myb-Etsl, c-myb, NF-M, or C/EBPct. As shown in Figure 6A , the mira-1 gene was induced efficiently in the fibroblasts transfected with any combination of plasmids expressing NF-M or rat C/EBP~ plus either form of Myb, indicating that both C/EBP-like proteins can cooperate with Myb {lanes 6-91. In contrast, none of the plasmids induced significant mira-1 expression when transfected singly, although some very weak, near background-level expression was observed in some experiments (lanes 2-5). The same Northern blot was rehybridized with a lysozymespecific probe. Figure 6B shows that lysozyme gene expression was also induced by a combination of Myb and C/EBP proteins, suggesting that the combination of Myb plus C/EBP may induce a number of myeloid genes besides mim-1. Interestingly, v-Myb in combination with either NF-M or C/EBPct was a more potent inducer than c-Myb. Whether this represents an intrinsic difference between v-Myb and c-Myb, whether it reflects the fact that v-Myb is fused to v-Ets, or whether it is simply the result of differences in expression levels remains to be tested. Thus, ectopic expression of the transcription factors Myb and NF-M or Myb and C/EBPa was sufficient to induce the expression of both the mira-1 and lysozyme genes in heterologous cells. We conclude that Myb and NF-M constitute a bipartite, combinatorial signal that activates the expression of myeloid genes like mim-I and lysozyme, even in the inappropriate cell type.
Discussion
In this paper we have described a combinatorial system of tissue-specific gene activation that is capable of inducing the expression of a myeloid cell-specific gene, mim-1, even in heterologous cell types. The signal is composed of two transcription factors, c-myb (or v-myb} and NF-M (C/EBPf~}, each of which is expressed in a particular tissue-specific pattern. The only cells that normally express both proteins are promyelocytes, the precursors of heterophils (chicken neutrophil granulocytes}.
They are also the only ceils that express the mim-1 gene. We found that the mim-1 promoter binds both factors and that ectopic expression of Myb and NF-M in nonmyeloid cells results in activation of the resident mim-1 gene in such cells. This indicates that the combination of Myb with NF-M serves as a signal for the induction of myeloid-specific gene expression, much as MyoD1 and myogenin induce muscle-specific genes in nonmuscle cells (Davis et al. 1987; Wright et al. 1989) .
Mechanism of cooperation between Myb and NF-M
Point mutations that disrupt the binding of either Myb or NF-M greatly impair the activity of the mim-1 promoter, indicating that both must bind to induce full activity. This suggests that the two factors act directly to activate mim-I expression. The situation is less clear for the lysozyme gene because its promoter is not known to contain Myb-binding sites or to be regulated by Myb. However, an important distal regulatory region, the -6.1-kb enhancer, which has been shown to confer cell type specificity to the lysozyme gene {Grewal et al. 1992), does contain at least one binding site for NF-M {E. Kowenz-Leutz and A. Leutz, unpubl.l . It is therefore intriguing that lysozyme expression should be induced by the Myb/NF-M combination, because it may imply that the two transcription factors are able to induce heterologous cells to undergo a more general switch to the myeloid differentiation pathway. The lysozyme gene might be induced as an indirect result of such a switch.
The Myb and NF-M proteins bind the mira-1 promoter at adjacent sites, leading us to speculate that they might form a stable complex in solution. Such a possibility is supported by the finding that the second repeat of the DNA-binding domain of Myb, a helix-turn-helix motif (Frampton et al. 1989 (Frampton et al. ,1991 , contains a potential protein-protein interaction site. This site was defined by mutations, present exclusively in the Myb protein encoded by AMV, which have no effect on its ability to bind DNA, but nevertheless eliminate the ability of the protein to activate mira-1 (Ness et al. 1989; Introna et al. 1990 ). So far, attempts to demonstrate a direct interaction between Myb and NF-M have been unsuccessful (E. Kowenz-Leutz, A. Leutz, and S. Ness, unpubl.}, although we cannot rule out the possibility that the proteins might interact via one or more bridging factors that are missing from our assays. In any case, it seems likely that Myb and NF-M must bind in close apposition to ensure that a functional connection is established with the basic transcription machinery. Further experiments should help distinguish between these alternatives.
Molecular controls of myeloid differentiation and transformation
We have suggested that the combination of Myb plus NF-M constitutes a combinatorial signal for myeloid gene expression. Although only two genes have been shown to be induced by this combination so far, it is likely that more will be found very soon. Our experiments have relied on Northern blots of transiently transfected fibroblasts and erythroid cells. The inefficiencies involved in such transfections make this a rather insensitive method and limit its usefulness to genes that are expressed abundantly, such as mirn-1 and lysozyme. The development of stable cell lines with regulatable versions of Myb and NF-M should lead to the isolation of more genes that are regulated in this way. Like lysozyme, many of these genes may be regulated only indirectly by Myb, which may only be required for the onset of the myeloid differentiation pathway. For example, the cMGF gene is regulated by a combination of NF-M and an AP-l-like factor (Stemeck et al. 1992 ), and we have recently observed that two other myeloid-specific genes can be activated in fibroblasts by transfection with NF-M only (E. Kowenz- Leutz and A. Leutz, unpubl.) . Certainly, other types of transcription factors, such as retinoic acid receptor-~ {Tsai et al. 1992), also play an important role in the lineage determination of myelomonocytic cells.
The observation that c-myb is essential for erythroid (Mucenski et al. 1991} and probably lymphoid cell growth and differentiation suggests that it also participates in the regulation of nonmyeloid genes. Do lymphoid-and erythroid-specific, perhaps NF-M-related proteins, cooperate with Myb to activate tissue-specific genes in those cell types? Mobility-shift assays have failed to detect NF-M-like DNA-binding proteins in lymphoid or erythroid ceils (Haas et al. 1992; Sterneck et al. 1992] , and C/EBP isoforms have been identified in myelomonocytic but not in other hematopoietic cells (Scott et al. 1992) . This suggests that the myelomonocytic cells may be the only ones that express Myb and C/EBP-like proteins simultaneously. Thus, if Myb cooperates with tissue-specific factors in nonmyeloid cells, it seems likely that they will be unrelated to NF-M.
The induction of myeloid gene expression in nonmyeloid cell types has been described previously. Several laboratories have reported that a combination of activated forms of the raf and myc oncogenes can induce mouse B cells to become macrophage-like (Klinken et al., 1988J . This switch results in the expression of numerous myeloid-specific genes in cells that have retained rearranged immunoglobulin genes characteristic of B cells. However, the switch occurs only at low frequency, making analysis of the early events extremely difficult. It is relevant to point out that in v-myc-transformed chick macrophages the expression of v-rail (the chicken homolog of raf) leads to induction of the NF-M-regulated cMGF gene (Adkins et al. 1984 , Katz et al. 1993 ). Thus, it will be interesting to test whether kinase oncogenes like raf/mil activate, in some way, the expression or the activity of NF-M and, if so, whether the introduction of NF-M into B cells might induce them to acquire myelomonocytic properties.
A final question raised by our studies is whether the target genes critical for cell transformation by v-myb are also under the control of NF-M. The v-myb oncogenes are somewhat unique in that they exclusively transform hematopoietic cells. Myb, itself, only transforms myeloid cells efficiently (Nunn and Hunter 1989; Introna et al. 1990; Metz and Graf 1991) would transform nontarget cells, such as fibroblasts, provided that these are cotransfected with NF-M. Such experiments, which are currently in progress, might ultimately help in elucidating the mechanism of myeloidspecific cell transformation and leukemogenesis.
Materials and methods
Cells, media, and culture conditions
The quail fibroblast cell line QT6 and the chicken cell lines HD3 (immature erythroid}, HDll (macrophagesl, and HD57 (myeloid/erythroid progenitors) have been described {Moscovici et al. 1977; Beug et al. 1979; Adkins et al. 1985; Graf et al. 1992) . MSB-1 and RPL-12 are chicken T-and B-lymphoid cell lines, respectively (Beug et al. 1979) . NIH-3T3 cells were obtained from R. Miiller {Institut ffir Molekularbiologie and Tumorforschung, Marburg, Germany). Primary E26 virus-transformed myeloblasts were derived from infected bone marrow cells as described previously (Beug et al. 1981; Ness et al. 1989 ). All were grown in Dulbecco's modified Eagle medium supplemented with 8% fetal bovine serum, 2% heat-inactivated chicken serum, 10 mM HEPES-NaOH {pH 7.2], plus penicillin, and streptomycin (all from GIBCO/BRL). Primary myeloid cell cultures were supplemented with 20 U/ml of recombinant cMGF (Leutz et al. 1989) or concanavalin A-stimulated chicken spleen cell supernatant as a source of the same . Avian and mouse cells were maintained in 5% CO2 at 39~ and 37~ respectively.
Transient transfections and promoter activation assays
DNA transfections using DEAE--dextran, preparation of cell extracts, and reporter gene assays were all performed as described previously (Ness et al. 1989; Sterneck et al. 1992) . COS-7 ceils were transfected either with lipofectin {BRL) according to the manufacturer's instructions or with DEAE-dextran (Levesque et al. 1991 t. The mira-1 promoter-luciferase reporter gene constructs and the Myb expression vectors have been described (Ness et al. 1989; Introna et al. 1990 ). The cytomegalovirus (CMV) promoter-NF-M expression vectors were prepared by transferring an NF-M eDNA into the pCDM8 expression vector, as described elsewhere (Katz et al. 1993j . Luciferase assays were performed using a Biolumat 9501 luminometer from Berthold.
Results are reported as luciferase activity normalized either for an internal ([3-galactosidase) control of transfection efficiency or for milligrams of extract protein assayed. For Northern blot analysis, RNAs were prepared 30-36 hr after transfection, either with a guanidinium-HC1 method (Chomczynski and Sacchi 1987} or by SDS/proteinase-K treatment [Vennstr6m and Bishop 1982} . Poly(A) + RNAs were prepared by oligoldT~cellulose chromatography [Aviv and Leder 1972; Vennstr6m and Bishop 19821 .
PCR mutagenesis
Point mutations in the mim ~I promoter were made by polymerase chain reaction (PCR)-mediated site-directed mutagenesis, by modifying published procedures (Higuchi et al. 19881 . For deletion mutants, the 5'-most amplimer contained extra nudeotides, resulting in a product with an additional BamHI site added. In each case, the final products were digested with the appropriate restriction enzymes (usually BamHI and XhoI), purified by agarose gel electrophoresis, and recloned into the luciferase expression vector pXP2 [Nordeen 1988 ). The authenticity of each recombinant was confirmed by DNA sequencing and by DNase I footprint analysis using bacterially expressed Myb protein [Ness et al. 1989; Lim et al. 19921 .
Recombinant transcription factors
The construction and characterization of the NI:-M expression vectors are described in detail elsewhere (Katz et al. 1993) . Briefly, the NF-M cDNA clone was transferred to the pATH2 vector, and expression of the resulting trpE-NF-M fusion protein was induced by tryptophan starvation. The recombinant NF-M was recovered from inclusion bodies by extraction with urea (Desplan et al. 1985) . For expression in animal cells, an NF-M cDNA with an optimized eukaryotic translation initiation site [Kozak 1984 ) was transferred to the pCDM8 expression vector (Invitrogen), which has a CMV promoter (Seed 1987) . The 5D229 dominant-negative version was made in the same way, except the 5' end of the cDNA encoding the first 226 amino acids was also removed. The AP-1 expression plasmid encodes the chick v-jun and c-los cDNAs (Stemeck et al. 1992 ).
Synthetic oligonucleotides
The following synthetic oligonucleotides were used to introduce mutations into the mira-1 promoter-luciferase constructs (mismatched nucleotides are underlined): AM, 5'-CTAAAAA-ACCT__G_GTATAATGT-3' (A box); BM, 5'-TAAGACACCCT_G_GTA-CTTTAG-3' (B boxl; CM, 5'-ATTTCGATCTT.GGTAATGTGA-3' (C box); M59, 5'-ACTGATTGGCGACCACAACAGTCGCA-3' (-60 site); M162, 5'-TCTTTCCCACACAGCTCTAAAAAAG-CG-3' 1-160 site}.
The following oligonucleotide pairs were used to make double-stranded probes for mobility-shift experiments {nucleotides added for labeling purposes are in small type):
A box [coding} [noncoding) BS60 {coding} {noncoding) BS160 {coding} {noncoding} C/EBP {codingJ [noncoding)
5'-tcgagCTAAAAAACCGTTATAATGTg-3' 3'-cGATTTTTTGGCAATATTACAcagct-8' 5'-tcgAGGACTGATTGGCCAACACAACAG-3' 3'-CCTGACTAACCGGTTGTGTTGTCAGct-5' 5'-tcgagCTGTCTTTCCCAACCAGCTCTg-3' 3'-cGACAGAAAGGGTTGGTCGAGAcagct-5' 5'-AATTCAATTGGGCAATCAGG-3' 3'-GTTAAGCCGTTAGTCCTTAA-3'
DNA-bindi'ng assays
Nuclear extracts from hematopoietic cells or CO8-7 cells were prepared as described (Stemeck et al. 1992) or by a mini-nuclear extract procedure (Schreiber et al. 1989) . Double-stranded oligonucleotide probes were labeled with [a-a2p]dCTP by end-filling with Klenow polymerase. Mobility shifts were performed exactly as described previously (Stemeck et al. 1992} . Where indicated, preimmune or polyclonal rabbit antisera raised against bacterially expressed chicken NF-M protein (Katz et al. 1993) was diluted 1/600 with PBS and added to the binding reaction 15 rain after mixing the nuclear extract and DNA. The samples were incubated for an additional 10 min on ice before electrophoresis.
RNA analysis
Total RNA was extracted using guanidinium isothiocyanate {Chomczynski and Sacchi 1987), and the poly{A) + fraction was isolated by oligo(dT}-cellulose chromatography (Aviv and Leder 1972) . RNAs were fractionated on 1% formaldehyde-agarose gels, transferred to Hybond membranes (Amersham}, UV crosslinked, and baked at 80~ for 2 hr. The restriction fragments used as probes for GAPDH, mira-l, and Iysozymc have been described (Dugaiczyk et al. 1983; Stueber et al. 1984; Ness et al. 19891 and were labeled by random priming (Stratagene kit). Hybridization was performed using QuikHyb {Stratagene) at 65~ for 2 hr. Subsequently, the filters were washed twice with 0.2 x SSC, 0.1% SDS, at 60~ and exposed to Kodak XAR5 X-ray film. Filters were rehybridized after stripping for 30 rain at 55~ in 50% formamide, 0.1% SDS, 0.1xSSC.
